Press Kit
Sandoz, the generic pharmaceuticals division of Novartis, is a global leader in the rapidly growing generics industry. The company, with nearly 26,000 employees, offers a broad portfolio of approximately 1 100 high-quality, affordable molecules across all major therapeutic areas and approximately 140 countries, and is a global leader in differentiated products. Today, Sandoz is one of the two largest global generic companies, with leading positions across the largest pharmaceutical markets worldwide.
